RESUMO
BACKGROUND: The minimum variance (MV) beamformer can significantly improve the image resolution in ultrasound imaging, but it has limited performance in noise reduction. We recently proposed the covariance matrix-based statistical beamforming (CMSB) for medical ultrasound imaging to reduce sidelobes and incoherent clutter. METHODS: In this paper, we aim to improve the imaging performance of the MV beamformer by introducing a new pixel-based adaptive weighting approach based on CMSB, which is named as covariance matrix-based adaptive weighting (CMSAW). The proposed CMSAW estimates the mean-to-standard-deviation ratio (MSR) of a modified covariance matrix reconstructed by adaptive spatial smoothing, rotary averaging, and diagonal reducing. Moreover, adaptive diagonal reducing based on the aperture coherence is introduced in CMSAW to enhance the performance in speckle preservation. RESULTS: The proposed CMSAW-weighted MV (CMSAW-MV) was validated through simulation, phantom experiments, and in vivo studies. The phantom experimental results show that CMSAW-MV obtains resolution improvement of 21.3% and simultaneously achieves average improvements of 96.4% and 71.8% in average contrast and generalized contrast-to-noise ratio (gCNR) for anechoic cyst, respectively, compared with MV. in vivo studies indicate that CMSAW-MV improves the noise reduction performance of MV beamformer. CONCLUSION: Simulation, experimental, and in vivo results all show that CMSAW-MV can improve resolution and suppress sidelobes and incoherent clutter and noise. These results demonstrate the effectiveness of CMSAW in improving the imaging performance of MV beamformer. Moreover, the proposed CMSAW with a computational complexity of [Formula: see text] has the potential to be implemented in real time using the graphics processing unit.
Assuntos
Algoritmos , Processamento de Sinais Assistido por Computador , Simulação por Computador , Processamento de Imagem Assistida por Computador/métodos , Imagens de Fantasmas , Ultrassonografia/métodosRESUMO
1. Cytochrome P450 2D (CYP2D) protein is widely expressed across brain regions in human and rodents. We investigated the interactions between tramadol, a clinically used analgesic, and brain CYP2D regulators, by establishing concentration-time curves of tramadol and O-desmethyltramadol (M1) in rat cerebrospinal fluid (CSF) and plasma, as well as by analyzing the analgesia-time course of tramadol. 2. Propranolol (20 µg, intracerebroventricular injection), CYP2D inhibitor, prolonged the elimination t1/2 of tramadol (40 mg/kg, intraperitoneal injection) in the CSF; meanwhile, lower Cmax and AUC0-∞ values of M1 were observed. Nicotine (1 mg base/kg, subcutaneous injection, seven days), brain CYP2D inducer, induced a shorter Tmax and elevated Cmax of M1 in CSF. No differences in the peripheral metabolism of tramadol were observed following propranolol and nicotine pretreatment. Nicotine increased areas under the analgesia-time curve (AUC) for 0-45 min and 0-90 min of tramadol, which was attenuated by propranolol administration. The analgesic actions of tramadol positively correlated with cerebral M1 concentration. 3. The results suggest that the regulation of brain CYP2D by xenobiotics may cause drug-drug interactions (DDIs) of tramadol. Brain CYPs may play an important role in DDIs of centrally active substances.
Assuntos
Sistema Enzimático do Citocromo P-450/metabolismo , Nicotina/farmacocinética , Propranolol/farmacocinética , Tramadol/farmacocinética , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Cromatografia Líquida , Interações Medicamentosas , Masculino , Nicotina/sangue , Nicotina/líquido cefalorraquidiano , Propranolol/sangue , Propranolol/líquido cefalorraquidiano , Ratos , Espectrometria de Massas em Tandem , Tramadol/análogos & derivados , Tramadol/sangue , Tramadol/líquido cefalorraquidianoRESUMO
The combined use of batifiban, a synthetic platelet GPII b/ IIIa receptor antagonist, and antithrombin agents is an attractive option for the treatment of patients with non-ST-segment elevation (NSTE) acute coronary syndrome (ACS) and those scheduled for percutaneous coronary intervention. To observe whether antithrombin agents affect the pharmacokinetic and pharmacodynamic properties of batifiban in combination therapy and optimize clinical administration dosage of batifiban, an open-label and parallel study was conducted. Thirty healthy subjects were randomly divided into three groups, which were sequentially treated with batifiban alone, or oral coadministration of clopidogrel, aspirin and UFH, or batifiban coadministered with these antithrombin agents. Blood samples were collected at pre-specified time points. The evaluation index included the inhibition of platelet aggregation and pharmacokinetic parameters. The pharmacokinetic parameters of batifiban and batifiban coadministered with antithrombin agents showed no significant differences. The mean inhibition rate of platelet aggregation (%) suggested that neither batifiban alone nor antithrombin agents alone could provide such potent inhibition rate (>80%) to obtain the best clinical efficacy, but they had a synergistic effect on platelet inhibition. No serious adverse effects were observed. The results in these healthy subjects suggest that batifiban coadministrated with antithrombin agents could achieve optimum clinical treatment effect for patients with NSTE ACS, and also those scheduled for percutaneous coronary intervention.
Assuntos
Aspirina/farmacologia , Heparina/farmacologia , Peptídeos Cíclicos/farmacocinética , Ticlopidina/análogos & derivados , Administração Oral , Adolescente , Adulto , Área Sob a Curva , Aspirina/administração & dosagem , China , Clopidogrel , Esquema de Medicação , Feminino , Fibrinolíticos/administração & dosagem , Fibrinolíticos/farmacologia , Heparina/administração & dosagem , Humanos , Infusões Intravenosas , Injeções Intravenosas , Masculino , Taxa de Depuração Metabólica/efeitos dos fármacos , Peptídeos Cíclicos/administração & dosagem , Inibidores da Agregação Plaquetária/administração & dosagem , Inibidores da Agregação Plaquetária/farmacocinética , Ticlopidina/administração & dosagem , Ticlopidina/farmacologia , Fatores de Tempo , Adulto JovemRESUMO
Population aging is a global problem, and improving the well-being of older adults is an urgent issue. Voice assistants (VAs) offer hands-free voice control and friendly human-computer interaction, making them a significant solution to address the aging problem. Most extant research on VAs is fragmented, and there are relatively few studies conducted from the perspective of emotional needs. This work proposes a comprehensive research model extending the technology acceptance model (TAM) by incorporating the influencing factors subordinate to two research directions: usability and emotional needs. Usability needs include three factors: perceived convenience, security/privacy, and Internet self-efficacy. Emotional needs include humanized interaction, perceived enjoyment, and perceived companionship. A structural equation model (SEM) was used to validate the model empirically with a sample of 425 older users of VAs. The analysis results are quite consistent with the research assumptions, and the findings illustrate that companionship is the most critical factor affecting older adults' intention to adopt VA use, which demonstrates the pivotal role of VAs in meeting the emotional needs of the elderly. The most unexpected observation was seen for the relationship between perceived ease of use and behavioral intention, which was non-significant. This result confirms that when a technology is perceived as very easy to use, perceived ease of use has little to no impact on individuals' intention to use that technology. The novelty of this study lies in the investigation of older adults' behavioral intentions toward using VAs, providing valuable insights for the design and development of VAs tailored for the elderly population. Beyond the academic realm, this research serves as direct inspiration for designers, developers, and policymakers in the fields of assistive technologies and geriatric care. It offers practical insights into creating VAs that effectively address the emotional needs of older adults and enhance their quality of life. Furthermore, elderly individuals are poised to experience significant benefits from the outcomes of this studyï¼the insights garnered from this study empower the elderly to embrace technological advancements that align with their preferences and comfort levels. This study contributes to a more comprehensive understanding of VAs and their potential to enhance the well-being of older adults, while also paving the way for future investigations in this domain. As underscored by this study's emphasis on the significance of emotional needs in technology acceptance, it encourages the adoption of more user-centered design strategies in the development of future VAs.
RESUMO
BACKGROUND: Pixel-based beamforming realizes dynamic focusing at the pixel level with a focused beam by assuming that the received signals are composed of spherical pulses. Far-focused pixel-based (FPB) imaging was proposed to avoid artifacts around the focal depth. However, the contrast improvement is limited. OBJECTIVE: We propose an adaptive weighting method based on dynamic phase coherence factor (DPCF) to improve the image contrast while preserving the speckle pattern. METHODS: The phase variation is dynamically estimated based on the noise energy proportion of echo signals and it is used to calculate phase coherence weights for suppressing interference and preserving desired signals. A depth-dependent parameter is designed for DPCF to enhance the performance of noise and clutter suppression in the far-field region. We further use the subarray averaging technique to smooth the speckle texture. RESULTS: The proposed method was evaluated on simulated, phantom experimental, and in vivo data. Results show that, compared with the phase coherence factor (PCF) based method, DPCF respectively leads to average CR improvements by more than 60% and 24% in simulation and experiment, while obtaining an improved speckle signal-to-noise ratio. CONCLUSIONS: The proposed method is a potentially valuable approach to obtaining high-quality ultrasound images in clinical applications.
Assuntos
Algoritmos , Processamento de Imagem Assistida por Computador , Humanos , Ultrassonografia/métodos , Razão Sinal-Ruído , Imagens de Fantasmas , Radiografia , Processamento de Imagem Assistida por Computador/métodosRESUMO
Glycerol 3-phosphate dehydrogenase 1 (GPD1) acts as a tumor suppressor in various types of cancer. However, the mechanisms of GPD1 anti-tumor remain unclear in breast cancer. This study aims to explore the function and clinical relevance of GPD1 in breast cancer. We confirmed that GPD1 inhibited the ability of proliferation, migration, and invasion in GPD1 overexpression breast cancer cells by CCK-8, wound healing, and Transwell assays, respectively. We found that GPD1 overexpression activated the lipid synthesis pathway and PI3K/AKT signaling pathway. The inhibitory effect of GPD1 on breast cancer cells was also weakened after treatment with LY294002, a PI3K/AKT pathway inhibitor. These results indicated that GPD1 suppressed the carcinogenesis of breast cancer through increasing PI3K/AKT-mediated lipid signaling pathways. Meanwhile, we detected that the relationship between GPD1 level and survival rate presents a positive correlation in breast cancer patients from the Cancer Genome Atlas (TCGA) database. Therefore, GPD1 can be a prognostic biomarker and target in developing therapeutic strategies for breast cancer patients.
RESUMO
Medical ultrasound image quality is often limited by clutter, which is the dominant mechanism of image degradation. A variety of beamforming methods have been extensively studied to reduce clutter and, thus, enhance ultrasound image quality. This article introduces a new beamforming approach, called covariance matrix-based statistical beamforming (CMSB), to improve the image contrast and preserve the background speckle pattern while simultaneously achieving a high-resolution performance. In CMSB, adaptive selection of subarray length, diagonal reducing, and mean-to-standard-deviation ratio-based subarray averaging are inherently combined to differentiate and reduce off-axis energy effectively. Moreover, rotary averaging prior to diagonal reducing is introduced to preserve speckle statistics. Simulated, experimental, and in vivo datasets were used to evaluate the imaging performance of the proposed method. The quantitative results indicate that, compared with delay-and-sum (DAS) beamforming, CMSB leads to average improvements of 44.5% and 97.3% in lateral resolution and contrast, respectively, in phantom experiments. Our work shows that CMSB is capable of improving image resolution and contrast while maintaining the speckle reliably. Preliminary in vivo study also demonstrates that the CMSB can enhance image contrast and lesion detection.
Assuntos
Algoritmos , Processamento de Imagem Assistida por Computador , Imagens de Fantasmas , UltrassonografiaRESUMO
Growing international trade requires more flexible warehouse management to match it. In order to achieve more effective warehouse management efficiency, a shelf status-detection method based on deep learning is proposed. Firstly, the image acquisition of a multi-level shelf containing multiple bays is performed under different time and lighting conditions. Due to the difference in image characteristics between the bottom shelf on the ground and the upper shelf on the non-ground level, the collected images were divided into two groups: floor images and shelf images; and the warehouse status recognition was performed on the two groups separately. The two sets of images are cropped and center projection transformed separately to obtain the region of interest. On this basis, the improved residual network model is used to construct different depot detection models for the two sets of images, respectively, and the above algorithm is verified by actual measurements. In this paper, 102,614 images of 3246 depots with different states of non-ground layer, and 27,903 images of ground layer are collected. They are divided into training set and test set according to the ratio of 4:1, and the accuracy of training set is 99.6%, and the accuracy of test set is 99.3%. The experimental outcomes provide a theoretical method and technical support for the intelligent warehouse system management.
Assuntos
Aprendizado Profundo , Algoritmos , Comércio , Internacionalidade , Redes Neurais de ComputaçãoRESUMO
Breast cancer is the most common form of cancer among women globally, and chemoresistance is a major challenge to disease treatment that is associated with a poor prognosis. This study was formulated to identify a reliable prognostic biosignature capable of predicting the survival of patients with chemoresistant breast cancer (CRBC) and evaluating the associated tumor immune microenvironment. Through a series of protein-protein interaction and weighted correlation network analyses, genes that were significantly associated with breast cancer chemoresistance were identified. Moreover, univariate Cox regression and lasso-penalized Cox regression analyses were employed to generate a prognostic model, and the prognostic utility of this model was then assessed using time-dependent receiver operating characteristic (ROC) and Kaplan-Meier survival curves. Finally, The CIBERSORT and ESTIMATE algorithms were additionally leveraged to assess relationships between the tumor immune microenvironment and patient prognostic signatures. Overall, a multigenic prognostic biosignature capable of predicting CRBC patient risk was successfully developed based on bioinformatics analysis and in vitro experiments. This biosignature was able to stratify CRBC patients into high- and low-risk subgroups. ROC curves also revealed that this biosignature achieved high diagnostic efficiency, and multivariate regression analyses indicated that this risk signature was an independent risk factor linked to CRBC patient outcomes. In addition, this signature was associated with the infiltration of the tumor microenvironment by multiple immune cell types. In conclusion, the chemoresistance-associated prognostic gene signature developed herein was able to effectively evaluate the prognosis of CRBC patients and to reflect the overall composition of the tumor immune microenvironment.
Assuntos
Biomarcadores Tumorais/genética , Neoplasias da Mama/genética , Biologia Computacional/métodos , Resistencia a Medicamentos Antineoplásicos , Bases de Dados Genéticas , Feminino , Perfilação da Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Humanos , Prognóstico , Análise de Sobrevida , Microambiente TumoralRESUMO
Combined antithrombotic regimens for atrial fibrillation (AF) patients with coronary artery disease, particularly for those who have acute coronary syndrome (ACS) and/or are undergoing percutaneous coronary intervention (PCI), presents a great challenge in the real-world clinical scenario. Conventionally, a triple antithrombotic therapy (TAT), which consists of combined oral anticoagulant therapy to prevent systemic embolism or stroke along with dual antiplatelet therapy to prevent coronary arterial thrombosis (CAT), is used. However, TAT has been associated with a significantly increased risk of bleeding. With the emergence of non-vitamin K antagonist oral anticoagulants (NOACs), randomized controlled trials have demonstrated a better risk-to-benefit ratio of dual antithrombotic therapy (DAT) in combination of a NOAC and with a P2Y12 inhibitor than vitamin K antagonist-based TAT. The results of these studies have impacted the recommendations of current international guidelines, which favor a DAT with a NOAC and P2Y12 inhibitor (especially clopidogrel) in this clinical setting. Additionally, aspirin can be administered during the periprocedural period, while the treatment duration of TAT should be as short as possible. In this article, we summarize the up-to-date evidence regarding antithrombotic regimens for AF patients with PCI or ACS, with a specific focus on the optimal approach and critical discussions of key scientific data and future developments for antithrombotic management in these patients.
RESUMO
Glaucoma, characterized with progressive degeneration of retinal ganglion cells (RGCs), is the second frequently leading cause of sight loss in the word after cataract. Baicalin plays a protective role in age-related macular degeneration, retinopathy of prematurity, branch retinal vein occlusion, and ischemia-induced neurodegeneration in the retina. The present study aimed to investigate the role of baicalin in glaucoma. RGCs were stimulated with N-methyl-D-aspartate (NMDA) to mimic the in vitro model of glaucoma. A mouse model of glaucoma induced by chronic elevated intraocular pressure was also established. The apoptosis, oxidative stress, and autophagy of RGCs were detected by flow cytometry analysis, 2,7-dichlorodihydrofluorescein diacetate staining, and Western blotting, respectively. Retinal pathological changes were exhibited by hemotoxylin and eosin staining. Baicalin restrained the NMDA-induced cell apoptosis, autophagy, and oxidative stress of RGCs by activating the PI3K/AKT signaling in vitro. The elevated intraocular pressure-induced pathological changes in retinas of glaucoma mice were attenuated by baicalin. Moreover, the number of RGCs was significantly decreased in glaucoma mice, and then increased by baicalin treatment. Baicalin also inhibited autophagy and activated PI3K/AKT signaling in vivo. In conclusion, baicalin suppresses glaucoma pathogenesis by regulating the PI3K/AKT signaling in vitro and in vivo.
Assuntos
Flavonoides/uso terapêutico , Glaucoma/tratamento farmacológico , Glaucoma/enzimologia , Fosfatidilinositol 3-Quinases/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Transdução de Sinais , Animais , Autofagia/efeitos dos fármacos , Contagem de Células , Linhagem Celular , Modelos Animais de Doenças , Flavonoides/química , Flavonoides/farmacologia , Glaucoma/patologia , Masculino , Camundongos Endogâmicos C57BL , N-Metilaspartato , Estresse Oxidativo/efeitos dos fármacos , Células Ganglionares da Retina/efeitos dos fármacos , Células Ganglionares da Retina/metabolismo , Células Ganglionares da Retina/patologiaRESUMO
In this study, we developed a sensitive and efficient analytical approach combining a 96-well plate-based protein precipitation strategy with ultra-performance liquid chromatography electrospray ionization tandem mass spectrometry (UPLC-MS/MS) in order to assess the pharmacokinetic (PK) properties of sivelestat and its metabolite XW-IMP-A in samples of plasma from ALI/ARDS patients with SIRS. The samples were separated via gradient elution with a C18 column (Phenomenex Kinetex, C18, 2.6 µm, 100 Å, 50 × 2.1 mm) using 0.1 % formic acid aqueous solution (A) and acetonitrile-methanol (1:1, V:V) (B) as a mobile phase at a 0.6 mL/min flow rate. UPLC-MS/MS spectra were generated in positive ion mode, and multiple reaction monitoring (MRM) was used to detect the following transitions: m/z 435.1 â 360.0 for sivelestat, m/z 469.0 â 394.0 for sivelestat-IS, m/z 351.0 â 276.0 for XW-IMP-A, and m/z 384.9 â 310.0 for XW-IMP-A-IS. This assay was run for 2.5 min in total, and achieved lowest limit of quantitation values of 2.0 ng/mL and 0.5 ng/mL for sivelestat and XW-IMP-A, respectively, while remaining highly linear from 2-500 ng/mL for sivelestat (r2 ≥ 0.9900) and from 0.5-125 ng/mL for XW-IMP-A (r2 ≥ 0.9900). These validated data were consistent with US Food and Drug Administration (FDA) and European Medicines Agency (EMA) acceptance criteria. In addition, this method was successfully applied to the steady-state PK evaluation of ALI/ARDS patients with SIRS.
Assuntos
Síndrome do Desconforto Respiratório , Espectrometria de Massas em Tandem , China , Cromatografia Líquida de Alta Pressão , Cromatografia Líquida , Glicina/análogos & derivados , Humanos , Limite de Detecção , Reprodutibilidade dos Testes , Sulfonamidas , Síndrome de Resposta Inflamatória SistêmicaRESUMO
BACKGROUND: This study aimed to investigate the effect of long noncoding ribonucleic acids (RNAs) metastasis-associated lung adenocarcinoma transcript 1 (lnc-MALAT1) on regulating neuron apoptosis, neurite outgrowth and inflammation, and further explore its molecule mechanism in Alzheimer's disease (AD). METHODS: Control overexpression, lnc-MALAT1 overexpression, control shRNA, and lnc-MALAT1 shRNA were transfected into NGF-stimulated PC12 cellular AD model and cellular AD model from primary cerebral cortex neurons of rat embryo, which were established by Aß1-42 insult. Rescue experiments were performed by transferring lnc-MALAT1 overexpression and lnc-MALAT1 overexpression & miR-125b overexpression plasmids. Neuron apoptosis, neurite outgrowth and inflammation were detected by Hoechst-PI/apoptosis marker expressions, and observations were made using microscope and RT-qPCR/Western blot assays. PTGS2, CDK5 and FOXQ1 expressions in rescue experiments were also determined. RESULTS: In two AD models, lnc-MALAT1 overexpression inhibited neuron apoptosis, promoted neurite outgrowth, reduced IL-6 and TNF-α levels, and increased IL-10 level compared to control overexpression, while lnc-MALAT1 knockdown promoted neuron apoptosis, repressed neurite outgrowth, elevated IL-6 and TNF-α levels, but reduced IL-10 level compared to control shRNA. Additionally, lnc- MALAT1 reversely regulated miR-125b expression, while miR-125b did not influence the lnc- MALAT1 expression. Subsequently, rescue experiments revealed that miR-125b induced neuron apoptosis, inhibited neurite outgrowth and promoted inflammation, also increased PTGS2 and CDK5 expressions but decreased FOXQ1 expression in lnc-MALAT1 overexpression treated AD models. CONCLUSION: Lnc-MALAT1 might interact with miR-125b to inhibit neuron apoptosis and inflammation while promote neurite outgrowth in AD.
Assuntos
Doença de Alzheimer/metabolismo , MicroRNAs/metabolismo , Crescimento Neuronal/fisiologia , Neurônios/patologia , RNA Longo não Codificante/metabolismo , Doença de Alzheimer/patologia , Animais , Apoptose/fisiologia , Quinase 5 Dependente de Ciclina/metabolismo , Ciclo-Oxigenase 2/metabolismo , Fatores de Transcrição Forkhead/metabolismo , Regulação da Expressão Gênica/fisiologia , Inflamação/metabolismo , Inflamação/patologia , Camundongos , Neurônios/metabolismo , Células PC12 , RatosRESUMO
A rapid and sensitive method involving liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS) coupled to an intracerebral microdialysis technique was developed for the determination and pharmacokinetic investigation of tramadol and its major active metabolite O-desmethyltramadol (ODT) in rat brain. The microdialysis samples were separated on a C18 column and eluted with a mobile phase of acetonitrile-water-formic acid (50:50:0.1; v/v/v) at a flow rate of 0.3 mL/min. The ESI-MS/MS spectra were performed in electrospray positive ion mode, and the analytes were detected by multiple reaction monitoring (MRM) of the transitions m/z [M + H]+ 264.3 â 58.2 for tramadol, m/z [M + H]+ 250.3 â 58.3 for ODT, and m/z [M + H]+ 379.4 â 264.0 for ambroxol (internal standard; IS). The total run time was 4.0 min. A lower limit of quantitation (LLOQ) was achieved as 1 ng/mL for tramadol and 0.5 ng/mL for ODT, with excellent linearity over a concentration range of 1 ~ 500 ng/mL (r > 0.99) for tramadol and 0.5 ~ 50 ng/mL for ODT (r > 0.99), respectively. The proposed method was successfully applied to the pharmacokinetic studies of tramadol and ODT in rat brain. Copyright © 2017 John Wiley & Sons, Ltd.
Assuntos
Microdiálise/métodos , Espectrometria de Massas em Tandem/métodos , Tramadol/análogos & derivados , Tramadol/líquido cefalorraquidiano , Animais , Encéfalo/metabolismo , Cromatografia Líquida/métodos , Limite de Detecção , Masculino , Ratos , Ratos Wistar , Reprodutibilidade dos Testes , Espectrometria de Massas por Ionização por Electrospray/métodos , Tramadol/análise , Tramadol/metabolismoRESUMO
Glutamate is the major excitatory neurotransmitter in the brain, and chronic glutamate excitotoxicity has been thought to be involved in numerous neurodegenerative diseases. We investigated the effects of glutamate at concentrations lower than the usual extrasynaptic concentrations on the production of epoxyeicosanoids mediated by brain CYP2J. Glutamate increased CYP2J2 mRNA levels in astrocytes in a dose-dependent manner, while an antagonist of the metabotropic glutamate receptor subtype 5 (mGlu5 receptor) attenuated the glutamate-induced increases in CYP2J2 levels by glutamate. Glutamate increased the binding of cAMP response element-binding protein (CREB) with the CYP2J2 promoter, and the inhibition of the MAPK signaling pathway (ERK1/2, p38, and JNK) decreased the binding of CREB with the CYP2J2 promoter following the glutamate treatment. CREB activated the CYP2J2 promoter located at -1522 to -1317bp, and CREB overexpression significantly increased CYP2J2 mRNA levels. The CYP2J2 and mGlu5 mRNA levels were higher in the frontal cortex, hippocampus, cerebellum, and brainstem in adult rats that received a subcutaneous injection of monosodium l-glutamate at 1, 3, 5, and 7days of age. The data from the partial least-squares-discriminant analysis showed the epoxyeicosanoid profile of the hippocampus from the cerebellum, brain stem, and frontal cortex. The sum of the epoxyeicosatrienoic acids (EETs) and dihydroxyeicosatrienoic acids (DHETs) was increased by 1.16-fold, 1.18-fold, and 1.19-fold in the frontal cortex, cerebellum, and brain stem, respectively, in rats treated with monosodium l-glutamate compared with the control group. The results suggest that brain CYP2J levels and CYP2J-mediated epoxyeicosanoid production can be regulated by extrasynaptic glutamate. The glutamate receptors expressed in astrocytes may mediate the regulation of drug-metabolizing enzymes and the metabolome of endogenous substances by glutamate.
Assuntos
Encéfalo/efeitos dos fármacos , Proteína de Ligação a CREB/metabolismo , Sistema Enzimático do Citocromo P-450/metabolismo , Eicosanoides/metabolismo , Ácido Glutâmico/toxicidade , Quinases de Proteína Quinase Ativadas por Mitógeno/metabolismo , Animais , Astrócitos/efeitos dos fármacos , Encéfalo/metabolismo , Proteína de Ligação a CREB/genética , Linhagem Celular , Citocromo P-450 CYP2J2 , Sistema Enzimático do Citocromo P-450/genética , Relação Dose-Resposta a Droga , Feminino , Humanos , Injeções Subcutâneas , Sistema de Sinalização das MAP Quinases , Masculino , Quinases de Proteína Quinase Ativadas por Mitógeno/genética , Regiões Promotoras Genéticas , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Transdução de Sinais , Regulação para CimaRESUMO
The observation, decomposition and record of motion are usually accomplished through artificial means during the process of motion analysis. This method not only has a heavy workload, its efficiency is also very low. To solve this problem, this paper proposes a novel method to segment and recognize continuous human motion automatically based on machine vision for mechanical assembly operation. First, the content-based dynamic key frame extraction technology was utilized to extract key frames from video stream, and then automatic segmentation of action was implemented. Further, the SIFT feature points of the region of interest (ROIs) were extracted, on the basis of which the characteristic vector of the key frame was derived. The feature vector can be used not only to represent the characteristic of motion, but also to describe the connection between motion and environment. Finally, the classifier is constructed based on support vector machine (SVM) to classify feature vectors, and the type of therblig is identified according to the classification results. Our approach enables robust therblig recognition in challenging situations (such as changing of light intensity, dynamic backgrounds) and allows automatic segmentation of motion sequences. Experimental results demonstrate that our approach achieves recognition rates of 96.00 % on sample video which captured on the assembly line.
RESUMO
Cytochrome P450 metabolites of arachidonic acid (AA) belong to eicosanoids and are potent lipid mediators of inflammation. It is well-known that eicosanoids play an important role in numerous pathophysiological processes. Therefore, quantitative analysis of cytochrome P450 metabolites of AA, including hydroxyeicosatetraenoic acids (HETEs), epoxyeicosatreinoic acids (EETs), and dihydroxyeicosatrienoic acids (DHETs) can provide crucial information to uncover underlying mechanisms of cytochrome P450 metabolites of AA related diseases. Herein, we developed a highly sensitive method to identify and quantify HETEs, EETs, and DHETs in lipid extracts of biological samples based on stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry. To this end, a pair of stable isotope probes, 2-dimethylaminoethylamine (DMED) and d4-2-dimethylaminoethylamine (d4-DMED), were utilized to facilely label eicosanoids. The heavy labeled eicosanoid standards were prepared and used as internal standards for quantification to minimize the matrix and ion suppression effects in mass spectrometry analysis. In addition, the detection sensitivities of DMED labeled eicosanoids improved by 3-104 folds in standard solution and 5-138 folds in serum matrix compared with unlabeled analytes. Moreover, a good separation of eicosanoids isomers was achieved upon DMED labeling. The established method provided substantial sensitivity (limit of quantification at sub-picogram), high specificity, and broad linear dynamics range (3 orders of magnitude). We further quantified cytochrome P450 metabolites of AA in rat liver, heart, brain tissues and human serum using the developed method. The results showed that 19 eicosanoids could be distinctly detected and the contents of 11-, 15-, 16-, 20-HETE, 5,6-EET, and 14,15-EET in type 2 diabetes mellitus patients and 5-, 11-, 12-, 15-, 16-, 20-HETE, 8,9-EET, and 5,6-DHET in myeloid leukemia patients had significant changes, demonstrating that these eicosanoids may have important roles on the pathogenesis of type 2 diabetes mellitus and myeloid leukemia.
Assuntos
Ácido Araquidônico/metabolismo , Sistema Enzimático do Citocromo P-450/metabolismo , Ácido 8,11,14-Eicosatrienoico/análogos & derivados , Ácido 8,11,14-Eicosatrienoico/metabolismo , Animais , Encéfalo/metabolismo , Estudos de Casos e Controles , Cromatografia Líquida de Alta Pressão , Deutério , Diabetes Mellitus Tipo 2/metabolismo , Eicosanoides/metabolismo , Humanos , Ácidos Hidroxieicosatetraenoicos/metabolismo , Marcação por Isótopo , Leucemia Mieloide/metabolismo , Fígado/metabolismo , Masculino , Miocárdio/metabolismo , Especificidade de Órgãos , Ratos Sprague-Dawley , Espectrometria de Massas por Ionização por Electrospray , Espectrometria de Massas em TandemRESUMO
A selective, sensitive and accurate high-performance liquid chromatographic- tandem mass spectrometry (HPLC-MS/MS) method for simultaneous determination of iloperidone and its two active metabolites, P88 and P95, in human plasma has been first developed and validated. The analytes and internal standard (IS), pioglitazone hydrochloride, were extracted from human plasma via liquid-liquid extraction with ethyl acetate and separated on a CAPCELL PAK C18 MG IIIcolumn (150mm×2.0mm, 5µm) set at 40°C. The mobile phase was acetonitrile: 5mM ammonium formate containing 0.3% formic acid (pH 4.8) (25:75, v/v), with a flow rate of 0.35mL/min. The mass spectrometer was operated in multiple reaction monitoring (MRM) mode using the transitions m/z 427.2â261.2 for iloperidone, m/z 429.1â261.1 for P88 and P95, and m/z 357.1â133.7 for the I.S. (pioglitazone hydrochloride). The method was validated to be linear over the concentration range of 10-10,000pg/mL for iloperidone and P88, 50-15,000pg/mL for P95. The mean recoveries were more than 78.88%, and the intra- and inter-day precisions were less than 10.24% and accuracy was -5.78 to 5.40%, which indicated that the quantitative method was reliable and accurate. The validated method has been successfully applied to a human pharmacokinetic study of iloperidone and two active metabolites, P88 and P95, after oral administration of 4mg iloperidone tablets in 12 healthy Chinese volunteers.
Assuntos
Cromatografia Líquida/métodos , Isoxazóis/sangue , Isoxazóis/metabolismo , Piperidinas/sangue , Piperidinas/metabolismo , Antagonistas do Receptor 5-HT2 de Serotonina/sangue , Antagonistas do Receptor 5-HT2 de Serotonina/metabolismo , Espectrometria de Massas em Tandem/métodos , Antipsicóticos/sangue , Antipsicóticos/metabolismo , Antagonistas dos Receptores de Dopamina D2 , Humanos , Extração Líquido-Líquido/métodos , Masculino , Sensibilidade e EspecificidadeRESUMO
A sensitive, simple and rapid high-performance liquid chromatography coupled with positive ion electrospray ionization-tandem mass spectrometry (HPLC-ESI-MS/MS) method was developed for the simultaneous determination of amlodipine, atorvastatin and its metabolites ortho-hydroxy atorvastatin and para-hydroxy atorvastatin in human plasma. The analytes were extracted from human plasma through liquid-liquid extraction method. A mixture of methyl tert-butyl ether and ethyl acetate (50:50, v/v) was used as the extractant. The chromatographic separation was achieved on a CAPCELLPAK CR 1:4 (5 µm, 150 mm × 2.0 mm i.d.) column within 6.0 min with the mobile phase consisted of acetonitrile and ammonium acetate buffer (20mM) containing 0.3% formic acid (50:50, v/v). Data acquisition was carried out in multiple reaction monitoring (MRM) mode. The method was validated and was successfully applied to the bioequivalence study of combination tablets containing AM and AT with coadministered individual drugs in 50 healthy Chinese male volunteers.